HomeCLRB • NASDAQ
add
Cellectar Biosciences Inc
Previous close
$0.25
Day range
$0.24 - $0.26
Year range
$0.22 - $3.42
Market cap
11.46M USD
Avg Volume
727.06K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.40M | -46.67% |
Net income | -6.60M | 75.21% |
Net profit margin | — | — |
Earnings per share | -0.14 | 81.08% |
EBITDA | -6.34M | 46.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.91M | -65.26% |
Total assets | 16.04M | -62.61% |
Total liabilities | 7.79M | -73.17% |
Total equity | 8.25M | — |
Shares outstanding | 46.08M | — |
Price to book | 1.49 | — |
Return on assets | -77.09% | — |
Return on capital | -128.54% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -6.60M | 75.21% |
Cash from operations | -9.38M | 29.77% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -9.38M | -130.80% |
Free cash flow | -7.34M | -72.68% |
About
Founded
1996
Headquarters
Website
Employees
11
